These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Theoretical implications of the use of L-dopa in parkinsonism. A review. Klawans H; Ilahi MM; Shenker D Acta Neurol Scand; 1970; 46(4):409-41. PubMed ID: 4323341 [No Abstract] [Full Text] [Related]
23. Pathophysiology of drug-induced dyskinesias. Korczyn AD Neuropharmacology; 1972 Sep; 11(5):601-7. PubMed ID: 4275111 [No Abstract] [Full Text] [Related]
24. 2-Dimethylaminoethanol (deanol): a brief review of its clinical efficacy and postulated mechanism of action. Re' O Curr Ther Res Clin Exp; 1974 Nov; 16(11):1238-42. PubMed ID: 4279161 [No Abstract] [Full Text] [Related]
25. Observations on the range of efficacy of L-dopa. Klawans HL Confin Neurol; 1971; 33(3):133-45. PubMed ID: 4940610 [No Abstract] [Full Text] [Related]
26. L-dopa in neurological disease: current status. Yahr MD Res Publ Assoc Res Nerv Ment Dis; 1972; 50():494-511. PubMed ID: 4561071 [No Abstract] [Full Text] [Related]
27. [Problems and therapy of L-DOPA-induced dyskinesias]. Völler GW; Deze J; Gundlach U; Muschard F Nervenarzt; 1972 Nov; 43(11):584-6. PubMed ID: 4564994 [No Abstract] [Full Text] [Related]
28. Therapeutic uses and side effects of L-dopa. Boshes B Adv Intern Med; 1972; 18():219-49. PubMed ID: 4576081 [No Abstract] [Full Text] [Related]
29. L-dopa therapy in Parkinson's disease. Lipman IJ Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138 [No Abstract] [Full Text] [Related]
30. [Side effects occurring in the course of treatment of parkinsonism with L-dopa]. Kuran W Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001 [No Abstract] [Full Text] [Related]
31. L-Dopa in the treatment of parkinsonism. Calne DB Clin Pharmacol Ther; 1970; 11(6):789-801. PubMed ID: 4921292 [No Abstract] [Full Text] [Related] [Previous] [New Search]